iSpecimen Inc. ISPC

ISPC Company Overview

iSpecimen Inc. is a U.S.-based life sciences company that operates an online marketplace connecting researchers with human biospecimens and associated clinical data for medical research. The company primarily serves pharmaceutical companies, biotechnology firms, academic medical centers, diagnostic developers, and contract research organizations engaged in drug development, diagnostics, and translational medicine. iSpecimen operates within the healthcare technology, biospecimen procurement, and life sciences research services industries. Its core revenue driver is the facilitation of biospecimen sourcing transactions through its proprietary technology platform, which matches researcher demand with healthcare provider supply while supporting compliance, logistics, and data management requirements.

The company’s platform is designed to streamline access to ethically sourced and consented human specimens, including blood, tissue, serum, plasma, and rare disease samples. iSpecimen differentiates itself through a decentralized supplier network and software-driven procurement model that integrates healthcare providers, specimen suppliers, and researchers. The company was founded in 2009 and later became publicly traded on the Nasdaq Capital Market under the ticker ISPC following a public listing in 2021. Public filings and company disclosures indicate that the business evolved from a specimen brokerage model into a technology-enabled marketplace focused on improving speed, traceability, and compliance in biospecimen procurement.